Abstract
The present work reports the characterization of Fastuosain, a novel cysteine protease of 25kDa, purified from the unripe fruits of Bromelia fastuosa, a wild South American Bromeliaceae. Proteolytic activity, measured using casein and synthetic substrates, was dependent on the presence of thiol reagents, having maximum activity at pH 7.0. The present work reports cDNA cloning of Fastuosain; cDNA was amplified by PCR using specific primers. The product was 1096pb long. Mature fastuosain has 217 residues, and with the proregion has a total length of 324 residues. Its primary sequence showed high homology with ananain(74%), stem bromelain (66%) and papain (44%).
Keywords: Peptidase, plant peptidase, papain, bromelain, cysteine-protease, protease
Protein & Peptide Letters
Title: Preliminary Functional Characterization, Cloning and Primary Sequence of Fastuosain, a Cysteine Peptidase Isolated from Fruits of Bromelia fastuosa
Volume: 13 Issue: 1
Author(s): H. Cabral, A. M. Leopoldino, E. H. Tajara, L. J. Greene, V. M. Faca, R. P. Mateus, C. R. Ceron, W. A. de Souza Judice, L. Juliano and G. O. Bonilla-Rodriguez
Affiliation:
Keywords: Peptidase, plant peptidase, papain, bromelain, cysteine-protease, protease
Abstract: The present work reports the characterization of Fastuosain, a novel cysteine protease of 25kDa, purified from the unripe fruits of Bromelia fastuosa, a wild South American Bromeliaceae. Proteolytic activity, measured using casein and synthetic substrates, was dependent on the presence of thiol reagents, having maximum activity at pH 7.0. The present work reports cDNA cloning of Fastuosain; cDNA was amplified by PCR using specific primers. The product was 1096pb long. Mature fastuosain has 217 residues, and with the proregion has a total length of 324 residues. Its primary sequence showed high homology with ananain(74%), stem bromelain (66%) and papain (44%).
Export Options
About this article
Cite this article as:
Cabral H., Leopoldino M. A., Tajara H. E., Greene J. L., Faca M. V., Mateus P. R., Ceron R. C., de Souza Judice A. W., Juliano L. and Bonilla-Rodriguez O. G., Preliminary Functional Characterization, Cloning and Primary Sequence of Fastuosain, a Cysteine Peptidase Isolated from Fruits of Bromelia fastuosa, Protein & Peptide Letters 2006; 13 (1) . https://dx.doi.org/10.2174/092986606774502072
DOI https://dx.doi.org/10.2174/092986606774502072 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lipid-Activated Nuclear Receptors and Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Extracts and Flavonoids of <i>Passiflora</i> Species as Promising Anti-inflammatory and Antioxidant Substances
Current Pharmaceutical Design A Therapeutic Intervention With a Borderline Adolescent: The Inclusion in an Educational Community as a “Speaking Action”
Adolescent Psychiatry Occupational Allergy in Healthcare Workers
Recent Patents on Inflammation & Allergy Drug Discovery Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential
Recent Patents on Inflammation & Allergy Drug Discovery Antimicrobial and Anti-MRSA Effects of Three Extracts of Some Hypericum Species Against Standard Microorganisms and Methicillin Resistant Staphylococcus aureus (MRSA) Strains
Current Bioactive Compounds The Obesity Hypoventilation Syndrome
Current Respiratory Medicine Reviews Peganum harmala L. Differentially Modulates Cytochrome P450 Gene Expression in Human Hepatoma HepG2 Cells
Drug Metabolism Letters Ultrasound Assisted Faster and Milder Approach to 6H-pyrido[1,2-a] quinazolin-6-imine Derivatives as Potential Inhibitors of PDE4
Letters in Drug Design & Discovery Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents
Current Drug Targets Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
Current Drug Targets Recent Progress in Understanding of Structure, Ligand Interactions and the Mechanism of Activation of the β 2-Adrenergic Receptor
Current Medicinal Chemistry Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Omalizumab in Children with Severe Allergic Asthma: The Italian Real- Life Experience
Current Respiratory Medicine Reviews Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology An Updated Overview of Ethnomedicinal Uses, Phytochemical and Various Pharmacological Evaluations on the Plant <i>Capparis decidua</i> (Forssk.) Edgew.
Current Traditional Medicine Obesity as a Model of Premature Immunosenescence
Current Immunology Reviews (Discontinued) Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Current Drug Targets Sleep in Pediatric Pulmonary Diseases
Current Respiratory Medicine Reviews Nanosuspensions of Poorly Water Soluble Drugs Prepared by Top-down Technologies
Current Pharmaceutical Design